Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OBServaToIre National Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs

NCT06929182 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT06929182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06929182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OBServaToIre National Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2025
Completion date
July 1, 2035
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid syndrome (aps), direct oral anticoagulants (doacs), safety, thrombotic and bleeding events